Prognostic value of prepontine cistern invasion in nasopharyngeal carcinoma treated by intensity-modulated radiotherapy

被引:11
作者
Hung, Tsung-Min [1 ,2 ]
Chen, Chien-Cheng [2 ,3 ]
Lin, Chien-Yu [1 ,2 ]
Ng, Shu-Hang [2 ,3 ]
Kang, Chung-Jan [2 ,4 ]
Huang, Shiang-Fu [2 ,4 ]
Liao, Chun-Ta [2 ,4 ]
Fan, Kang-Hsing [1 ,2 ]
Wang, Hung-Ming [2 ,5 ]
Chang, Joseph Tung-Chieh [1 ,2 ]
机构
[1] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan
[2] Chang Gung Univ, Tao Yuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Diagnost Radiol, Tao Yuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Otorhinolaryngol Head & Neck Surg, Tao Yuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Tao Yuan, Taiwan
关键词
Nasopharyngeal carcinoma; Intensity-modulated radiotherapy; Prognosis; Prepontine cistern invasion; Distant metastasis; Intracranial extension; Head and neck cancer; BARR-VIRUS DNA; PHASE-II TRIAL; F-18-FDG PET; EXPERIENCE; CHEMOTHERAPY; CANCER;
D O I
10.1016/j.oraloncology.2013.12.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate the prognostic value of prepontine cistern invasion (PPCI) in nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiotherapy (IMRT). Materials and methods: Five hundred and four non-disseminated NPC patients who underwent magnetic resonance imaging examination before radical IMRT between November 2000 and December 2008 were retrospectively reviewed. The diagnostic criteria for PPCI were tumor invasion through the posterior cortex of clivus and extension into the prepontine cistern. Results: The median follow-up of the patients in this study was 63.5 months. PPCI was found in 44 patients (25% of T4 patients). The 5-year progression-free survival (PFS), local control (LC), distant metastasis- free survival (DMFS), and overall survival (OS) of all patients, with and without PPCI, were 44.3% and 70.5% (p < 0.001), 84.4% and 89.1% (p = 0.376), 66.6% and 87.3% (p < 0.001), and 59.6% and 80.2% (p < 0.001), respectively. In T4 patients with PPCI and without PPCI, the 5-year PFS, LC, DMFS, and OS were 44.3% and 62.5% (p = 0.023), 84.4% and 84.9% (p = 0.946), 66.6% and 83.1% (p = 0.022), and 59.6% and 71.0% (p = 0.045), respectively. Using multivariate analysis, PPCI was found to be an independent poor prognostic factor for PFS (HR = 1.816; p = 0.007), DMFS (HR = 1.928; p = 0.045), and OS (HR = 1.798; p = 0.016). Conclusion: Prepontine cistern invasion was an independent prognostic factor for poor DMFS and OS but not LC in NPC patients treated with IMRT, even within T4 patients. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:228 / 233
页数:6
相关论文
共 50 条
  • [41] Prognostic value of Diabetes in Patients with Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiation Therapy
    Peng, Hao
    Chen, Lei
    Zhang, Yuan
    Li, Wen-Fei
    Mao, Yan-Ping
    Zhang, Fan
    Guo, Rui
    Liu, Li-Zhi
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    SCIENTIFIC REPORTS, 2016, 6
  • [42] Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
    He, Yu-Xiang
    Wang, Ying
    Cao, Peng-Fei
    Shen, Lin
    Zhao, Ya-Jie
    Zhang, Zi-Jian
    Chen, Deng-Ming
    Yang, Tu-Bao
    Huang, Xin-Qiong
    Qin, Zhou
    Dai, You-Yi
    Shen, Liang-Fang
    CHINESE JOURNAL OF CANCER, 2016, 35 : 96
  • [43] CLINICAL OUTCOMES AND PATTERNS OF FAILURE AFTER INTENSITY-MODULATED RADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA
    Ng, Wai Tong
    Lee, Michael C. H.
    Hung, Wai Man
    Choi, Cheuk Wai
    Lee, Kin Chung
    Chan, Oscar S. H.
    Lee, Anne W. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (02): : 420 - 428
  • [44] Apolipoprotein A-I Is a Prognosticator of Nasopharyngeal Carcinoma in the Era of Intensity-modulated Radiotherapy
    Chang, Hui
    Wei, Jia-wang
    Chen, Kai
    Zhang, Shu
    Han, Fei
    Lu, Li-xia
    Xiao, Wei-wei
    Gao, Yuan-hong
    JOURNAL OF CANCER, 2018, 9 (04): : 702 - 710
  • [45] Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Orlandi, Ester
    Tomatis, Stefano
    Potepan, Paolo
    Bossi, Paolo
    Mongioj, Valeria
    Carrara, Mauro
    Palazzi, Mauro
    Franceschini, Marzia
    Bergamini, Cristiana
    Locati, Laura
    Iannacone, Eva
    Guzzo, Marco
    Ibba, Tullio
    Crippa, Flavio
    Licitra, Lisa
    Pignoli, Emanuele
    Fallai, Carlo
    FUTURE ONCOLOGY, 2013, 9 (01) : 103 - 114
  • [46] Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
    Wu, Shihai
    Quan, Rencui
    Han, Ling
    Zhang, Huaqing
    Zhang, Baozhu
    Xu, Gang
    Li, Xianming
    MEDICINE, 2020, 99 (30) : E21325
  • [47] Clinical Outcomes and Prognostic Factors of 695 Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiotherapy
    Wang, Weidong
    Feng, Mei
    Fan, Zixuan
    Li, Jie
    Lang, Jinyi
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [48] Preliminary results of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: a retrospective study of 364 patients
    Kong, Fangfang
    Ying, Hongmei
    Huang, Shuang
    Du, Chengrun
    Zhou, Junjun
    Hu, Chaosu
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2014, 271 (12) : 3283 - 3290
  • [49] Prognostic significance of tumor volume in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy
    Wu, Zheng
    Zeng, Rui-Fang
    Su, Yong
    Gu, Mo-Fa
    Huang, Shao-Min
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (05): : 689 - 694
  • [50] Prognostic implications of dynamic serum lactate dehydrogenase assessments in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy
    Zhou, Guan-Qun
    Ren, Xian-Yue
    Mao, Yan-Ping
    Chen, Lei
    Sun, Ying
    Liu, Li-Zhi
    Li, Li
    Lin, Ai-Hua
    Mai, Hai-Qiang
    Ma, Jun
    SCIENTIFIC REPORTS, 2016, 6